Total medical devices industry cross border deals worth $11.9bn were announced globally for August 2021, with the $7.3bn private equity deal with Inovalon Holdings being the sector’s biggest investment, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 154.9% over the previous month of $4.68bn and a rise of 77.5% when compared with the last 12-month average of $6.72bn.
In terms of number of cross border deals, the sector saw a drop of 25.00% with 33 deals in August 2021 when compared to the last 12-month average of 44 deals.
In value terms, North America led the activity with cross border deals worth $11.63bn in August 2021.
medical devices industry cross border deals in August 2021: Top deals
The top five cross border deals accounted for 95.9% of the overall value during August 2021.
The combined value of the top five cross border deals stood at $11.44bn, against the overall value of $11.9bn recorded for the month.
The top five medical devices industry cross border deals of August 2021 tracked by GlobalData were:
1) 22C Capital,Insight Partners and Nordic Capital $7.3bn private equity deal with Inovalon Holdings
2) The $2.5bn acquisition of Smiths Medical by Trulli Bidco
3) Medtronic $1.1bn acquisition deal with Intersect ENT
4) The $340m acquisition of BioVision by Abcam
5) Amplify Partners,Anzu Partners,Genoa Ventures,Heritage Provider Network,Irving Investors,SoftBank Group and True Ventures $201m venture financing deal with InterVenn BioSciences
